• LAST PRICE
    2.2200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.5600/ 10
  • Ask / Lots
    2.5000/ 2
  • Open / Previous Close
    0.0000 / 2.2200
  • Day Range
    ---
  • 52 Week Range
    Low 1.6700
    High 8.7300
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.23
TimeVolumeVYNE
09:32 ET12232.18
09:42 ET4002.17
09:50 ET4762.18
10:00 ET10002.2367
10:02 ET5002.17
10:04 ET35052.25
10:06 ET1532.2059
10:09 ET1002.1803
10:13 ET5002.17
10:15 ET1002.18
10:26 ET1002.18
10:27 ET1002.2
10:33 ET5002.18
10:44 ET5002.18
10:51 ET1002.25
10:56 ET2502.215
10:58 ET5002.2
11:00 ET47502.2
11:02 ET1002.2429
11:03 ET14762.23
11:12 ET5002.2
11:25 ET20032.205
11:32 ET1002.2
11:36 ET4932.1602
11:38 ET5002.17
11:39 ET1292.19
11:50 ET1032.18
11:54 ET3002.19
12:01 ET1002.19
12:03 ET5002.18
12:06 ET8392.18
12:21 ET4002.18
12:30 ET3002.2077
12:37 ET4502.18
12:39 ET22542.2
12:55 ET22572.2099
01:08 ET7442.225
01:09 ET2002.21
01:13 ET5002.19
01:20 ET3612.1901
01:27 ET2502.21
01:29 ET4002.18
01:31 ET1002.18
01:36 ET3902.2
01:40 ET5002.18
01:45 ET101142.22
01:47 ET2012.206
01:54 ET5002.2
01:56 ET3002.225
01:58 ET5002.2001
02:05 ET14002.2001
02:09 ET5002.17
02:12 ET6002.18
02:14 ET10382.1701
02:20 ET2312.17
02:23 ET3002.17
02:25 ET10002.178
02:30 ET9992.16
02:38 ET2002.17
02:39 ET6002.185
02:41 ET1002.18
02:43 ET6002.17
02:45 ET5002.185
02:54 ET12002.1701
02:56 ET4842.1767
02:57 ET4792.16
03:01 ET15002.16
03:12 ET9002.16
03:14 ET3692.16
03:15 ET20002.1601
03:17 ET11002.1758
03:24 ET2002.19
03:26 ET22512.16
03:30 ET24322.19
03:33 ET3312.1601
03:37 ET80832.165
03:39 ET2002.12
03:42 ET11772.12
03:44 ET6002.16
03:46 ET3202.146
03:48 ET10002.1899
03:50 ET8002.18
03:53 ET10482.15
03:55 ET5002.1701
03:57 ET9002.1801
04:00 ET13162.22
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVYNE
Vyne Therapeutics Inc
31.3M
-0.2x
---
United StatesACST
Acasti Pharma Inc
32.3M
-0.7x
---
United StatesLEXX
Lexaria Bioscience Corp
35.6M
-3.5x
---
United StatesCHHE
China Health Industries Holdings Inc
25.6M
-190.2x
---
United StatesETST
Earth Science Tech Inc
23.0M
76.0x
---
United StatesMBRX
Moleculin Biotech Inc
20.4M
-0.7x
---
As of 2024-03-04

Company Information

VYNE Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing differentiated therapies for the treatment of immuno-inflammatory conditions. Its product candidate is VYN201, a locally administered pan-BET inhibitor designed as a soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways while providing low systemic exposure. Its second program is VYN202, a BD2-selective oral small molecule bromodomain and extra-terminal (BET) inhibitor in preclinical development for the treatment of immuno-inflammatory indications. Its FMX114 is investigational combination gel formulation of tofacitinib and fingolimod that is designed to address both the source and cause of inflammation in atopic dermatitis (AD). The Company has rights to research, develop and commercialize products containing BET inhibitor compounds for the treatment of any disease, disorder or condition in humans.

Contact Information

Headquarters
685 Route 202/206 N., Suite 301BRIDGEWATER, NJ, United States 08807
Phone
650-486-1416
Fax
302-655-5049

Executives

Chief Executive Officer, Director
David Domzalski
Chief Financial Officer, Treasurer
Tyler Zeronda
Chief Scientific Officer
Iain Stuart
Chief Legal Officer, General Counsel
Mutya Harsch
Lead Independent Director
Patrick Lepore

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$31.3M
Revenue (TTM)
$354.0K
Shares Outstanding
14.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.18
EPS
$-9.05
Book Value
$9.73
P/E Ratio
-0.2x
Price/Sales (TTM)
88.4
Price/Cash Flow (TTM)
---
Operating Margin
-8,590.68%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.